USP: Further Updates on "Residual Solvents" published for Comments
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
As recently reported, the USP chapter "<467> RESIDUAL SOLVENTS" has been revised and published for comment following the update of the "ICH guideline Q3C (R8) on impurities: guideline for residual solvents". As Chapter "<1467> RESIDUAL SOLVENTS-VERIFICATION OF COMPENDIAL PROCEDURES AND VALIDATION OF ALTERNATIVE PROCEDURES" refers to the information in Chapter <467>, the latter has now also been updated and the new draft is published on the USP Pharmacopeial Forum website. Comments and suggestions on this draft can be submitted until 31 March 2023.
In addition to formal changes, modifications have been made in the section "VERIFICATION OF COMPENDIAL PROCEDURES - Limit Procedures: Procedure A and Procedure B". Here, the changes are found in the sub-item "Specificity". They are also due to the addition of the substances "cyclopentyl methyl ether" and "tertiary butyl alcohol" as well as "2-methyltetrahydrofuran".
The draft chapter "<1467> RESIDUAL SOLVENTS-VERIFICATION OF COMPENDIAL PROCEDURES AND VALIDATION OF ALTERNATIVE PROCEDURES" can be consulted and commented on after completing a one-time registration on the Pharmacopeial Forum website.
Related GMP News
28.10.2026IPEC Publishes Version 3 of the Excipient Composition Guide
28.10.2026EMA and CMDh Expand List of Nitrosamine Limits
14.10.2026EMA Reports inconsistent Progress in International API Inspection Cooperation
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications